SCHEMBL30855097

SCHEMBL30855097

Nc1cc(-c2cc([C@@H]3COC[C@H](F)CN3)cc(Cl)n2)ncn1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.33
MAP3K12 Q12852 1/20 0.31
ASIC3 Q9UHC3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29334427 1.00 KMO (0.33) KMOMAP3K12ASIC3
SCHEMBL29334426 0.71 KRAS (0.34)
SCHEMBL29334239 0.64 KMO (0.38) KMO
SCHEMBL30855130 0.64 KMO (0.38) KMO
SCHEMBL29333545 0.63 MAPK1 (0.33)
SCHEMBL29334357 0.60 PRKACA (0.39)
SCHEMBL31008561 0.58 ASIC3 (0.50) KMOASIC3
SCHEMBL29334233 0.56 METTL3 (0.32)
SCHEMBL31224163 0.55
SCHEMBL25344301 0.53 IDH1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594308-A1 N-ACRYLOYLMORPHOLINE DERIVATIVES AS KEAP1 MODULATORS AND USES THEREOF Vividion Therapeutics, Inc. (US) 2025-08-06 EP disclosed
WO-2024073587-A1 N-ACRYLOYLMORPHOLINE DERIVATIVES AS KEAP1 MODULATORS AND USES THEREOF VIVIDION THERAPEUTICS, INC. (US) 2024-04-04 WO disclosed